Questions about how US President Donald Trump will shape FDA over the next four years may have driven agency staff to push out an unusually high number of guidances and regulations in the weeks leading up to the new president's inauguration.
An end-of-administration document dump is typical as outgoing staff rush to complete projects before a new president arrives, but data...